Breaking News - The Fly

Open Search

QLGN

Qualigen Therapeutics

$

()

Qualigen Therapeutics regains compliance with Nasdaq's min bid price

QLGN

12/5/2024 - 09:04am

Qualigen announces $4.5M private placement of Preferred Shares

QLGN

11/19/2024 - 09:03am

Qualigen Therapeutics trading halted, news pending

QLGN

11/4/2024 - 19:50pm

Qualigen Therapeutics to implement 1-for-50 reverse stock split

QLGN

11/1/2024 - 09:02am

Qualigen Therapeutics files to sell 14M shares of common stock

QLGN

10/24/2024 - 17:08pm

Qualigen Therapeutics appoints Kevin Richardson as Interim CEO and CFO

QLGN

9/26/2024 - 17:15pm

Qualigen Therapeutics receives extension from Nasdaq hearings panel

QLGN

9/20/2024 - 09:04am

Qualigen Therapeutics prices 14.7M shares at 13c in public offering

QLGN

9/5/2024 - 09:06am

Qualigen Therapeutics, Marizyme enter co-development agreement for DuraGraft

QLGN

4/16/2024 - 07:08am

Qualigen Therapeutics announces presentation on Pan-RAS Inhibitors

QLGN

4/10/2024 - 08:06am

Qualigen announces AACR poster featuring early clinical experience with QN-302

QLGN

4/9/2024 - 08:25am